Penserra Capital Management LLC Cara Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

  • $4.61 Billion
  • Q3 2024

A detailed history of Penserra Capital Management LLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Penserra Capital Management LLC holds 63,506 shares of CARA stock, worth $307,369. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63,506
Previous 68,078 6.72%
Holding current value
$307,369
Previous $18,000 5.56%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$0.26 - $0.38 $1,188 - $1,737
-4,572 Reduced 6.72%
63,506 $19,000
Q2 2024

Aug 13, 2024
BUY
$0.24 - $0.92 $609 - $2,336
2,540 Added 3.88%
68,078 $18,000
Q1 2024

May 15, 2024
SELL
$0.52 - $1.05 $8,322 - $16,804
-16,004 Reduced 19.63%
65,538 $59,000
Q3 2023

Nov 15, 2023
SELL
$1.67 - $3.33 $133,600 - $266,400
-80,000 Reduced 49.52%
81,542 $136,000
Q2 2023

Aug 11, 2023
BUY
$2.83 - $4.94 $3,543 - $6,184
1,252 Added 0.78%
161,542 $457,000
Q1 2023

Apr 24, 2023
SELL
$4.89 - $12.27 $79,198 - $198,724
-16,196 Reduced 9.18%
160,290 $787,000
Q4 2022

Feb 13, 2023
BUY
$8.88 - $12.77 $24,864 - $35,756
2,800 Added 1.61%
176,486 $1.9 Million
Q3 2022

Nov 14, 2022
SELL
$8.24 - $12.56 $206,000 - $314,000
-25,000 Reduced 12.58%
173,686 $1.63 Million
Q2 2022

Aug 15, 2022
BUY
$7.45 - $13.84 $71,609 - $133,030
9,612 Added 5.08%
198,686 $1.81 Million
Q1 2022

May 13, 2022
SELL
$9.94 - $12.65 $15,923 - $20,265
-1,602 Reduced 0.84%
189,074 $2.3 Million
Q4 2021

Feb 15, 2022
SELL
$11.99 - $18.14 $33,811 - $51,154
-2,820 Reduced 1.46%
190,676 $2.32 Million
Q3 2021

Nov 15, 2021
SELL
$11.55 - $16.06 $639,442 - $889,129
-55,363 Reduced 22.25%
193,496 $2.99 Million
Q2 2021

Aug 12, 2021
SELL
$12.38 - $29.19 $778,132 - $1.83 Million
-62,854 Reduced 20.16%
248,859 $3.55 Million
Q1 2021

May 13, 2021
BUY
$15.07 - $21.71 $2.98 Million - $4.29 Million
197,508 Added 172.94%
311,713 $6.77 Million
Q4 2020

Feb 12, 2021
BUY
$12.72 - $16.16 $614,185 - $780,285
48,285 Added 73.25%
114,205 $1.73 Million
Q3 2020

Nov 13, 2020
SELL
$12.34 - $17.92 $456 - $663
-37 Reduced 0.06%
65,920 $837,000
Q2 2020

Aug 14, 2020
BUY
$12.39 - $17.33 $120,715 - $168,846
9,743 Added 17.33%
65,957 $1.13 Million
Q1 2020

May 14, 2020
BUY
$9.12 - $17.78 $427,308 - $833,064
46,854 Added 500.58%
56,214 $741,000
Q4 2019

Feb 14, 2020
SELL
$16.11 - $25.98 $8,312 - $13,405
-516 Reduced 5.22%
9,360 $152,000
Q3 2019

Nov 15, 2019
BUY
$18.28 - $26.91 $180,533 - $265,763
9,876 New
9,876 $180,000

Others Institutions Holding CARA

# of Institutions
65
Shares Held
12.7M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $260M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email